ORCHARD: A phase II platform study in patients with advanced NSCLC who have progressed on first-line osimertinib therapy Meeting Abstract
| Authors: | Yu, H.; Goldberg, S.; Le, X.; Piotrowska, Z.; Smith, P.; Mensi, I.; Kirova, B.; Chmielecki, J.; Li-Sucholeicki, X.; Szekeres, P.; Doughton, G.; Patel, G.; Jewsbury, P.; Riess, J. |
| Abstract Title: | ORCHARD: A phase II platform study in patients with advanced NSCLC who have progressed on first-line osimertinib therapy |
| Meeting Title: | 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC) |
| Keywords: | resistance; nsclc; osimertinib |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 14 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2019 Sept 7-10 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-10-01 |
| Start Page: | S647 |
| Language: | English |
| ACCESSION: | WOS:000492162203281 |
| DOI: | 10.1016/j.jtho.2019.08.1366 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P2.01-22 -- Source: Wos |
